For those who appreciate value investing, NYSE:HAE is a compelling option with its solid fundamentals.

Discover HAEMONETICS CORP/MASS (NYSE:HAE)—an undervalued stock our stock screener has picked out. NYSE:HAE demonstrates solid fundamentals, including health and profitability, all while staying attractively priced. Let's explore the details.

What does the Valuation looks like for NYSE:HAE

ChartMill employs its own Valuation Rating system for all stocks. This score, ranging from 0 to 10, is determined by evaluating different valuation factors, including price to earnings and free cash flow, both in absolute terms and relative to the market and industry. NYSE:HAE has earned a 8 for valuation:

• 92.11% of the companies in the same industry are more expensive than HAE, based on the Price/Earnings ratio.
• HAE's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 28.37.
• HAE is valuated reasonably with a Price/Forward Earnings ratio of 11.82.
• Compared to the rest of the industry, the Price/Forward Earnings ratio of HAE indicates a rather cheap valuation: HAE is cheaper than 94.74% of the companies listed in the same industry.
• HAE is valuated cheaply when we compare the Price/Forward Earnings ratio to 96.21, which is the current average of the S&P500 Index.
• Based on the Enterprise Value to EBITDA ratio, HAE is valued cheaper than 88.42% of the companies in the same industry.
• 68.95% of the companies in the same industry are more expensive than HAE, based on the Price/Free Cash Flow ratio.
• HAE's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
• HAE has an outstanding profitability rating, which may justify a higher PE ratio.
• HAE's earnings are expected to grow with 15.51% in the coming years. This may justify a more expensive valuation.

Profitability Analysis for NYSE:HAE

Discover ChartMill's exclusive Profitability Rating, a proprietary metric that assesses stocks on a scale of 0 to 10. It takes into consideration various profitability ratios and margins, both in absolute terms and relative to industry peers. Notably, NYSE:HAE has achieved a 9:

• HAE has a Return On Assets of 4.90%. This is amongst the best in the industry. HAE outperforms 83.68% of its industry peers.
• HAE has a Return On Equity of 14.09%. This is amongst the best in the industry. HAE outperforms 88.42% of its industry peers.
• With an excellent Return On Invested Capital value of 7.59%, HAE belongs to the best of the industry, outperforming 86.84% of the companies in the same industry.
• The 3 year average ROIC (7.51%) for HAE is below the current ROIC(7.59%), indicating increased profibility in the last year.
• Looking at the Profit Margin, with a value of 9.10%, HAE belongs to the top of the industry, outperforming 83.68% of the companies in the same industry.
• HAE's Profit Margin has improved in the last couple of years.
• HAE's Operating Margin of 15.80% is amongst the best of the industry. HAE outperforms 85.79% of its industry peers.
• HAE's Operating Margin has improved in the last couple of years.
• In the last couple of years the Gross Margin of HAE has grown nicely.

ChartMill's Evaluation of Health

ChartMill employs a unique Health Rating system for all stocks. This rating, ranging from 0 to 10, is determined by analyzing various liquidity and solvency ratios. For NYSE:HAE, the assigned 5 for health provides valuable insights:

• HAE has a Altman-Z score of 2.50. This is in the better half of the industry: HAE outperforms 64.21% of its industry peers.
• HAE's Debt to FCF ratio of 39.37 is fine compared to the rest of the industry. HAE outperforms 67.89% of its industry peers.
• A Current Ratio of 3.49 indicates that HAE has no problem at all paying its short term obligations.
• The Current ratio of HAE (3.49) is better than 63.68% of its industry peers.
• A Quick Ratio of 2.09 indicates that HAE has no problem at all paying its short term obligations.

What does the Growth looks like for NYSE:HAE

ChartMill employs its own Growth Rating system for all stocks. This score, ranging from 0 to 10, is derived by evaluating different growth factors, such as EPS and revenue growth, taking into account both past performance and future projections. NYSE:HAE has earned a 6 for growth:

• HAE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 9.87%, which is quite good.
• HAE shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 10.74% yearly.
• Looking at the last year, HAE shows a quite strong growth in Revenue. The Revenue has grown by 12.01% in the last year.
• The Earnings Per Share is expected to grow by 17.65% on average over the next years. This is quite good.
• Based on estimates for the next years, HAE will show a quite strong growth in Revenue. The Revenue will grow by 8.79% on average per year.
• The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
• The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

More Decent Value stocks can be found in our Decent Value screener.

Check the latest full fundamental report of HAE for a complete fundamental analysis.

Keep in mind

This is not investing advice! The article highlights some of the observations at the time of writing, but you should always make your own analysis and invest based on your own insights.